Early identification and standardization of clinical treatments are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological activation. The platform can help to combine teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs.
Treatment and management of early-onset rheumatoid arthritis multi-junctional RF-positive treatments need to be individualized, typically including multidimensional management, including drug therapy, rehabilitation interventions, regular follow-up, and more. In recent years, with the development of targeted therapy, immune-regulated therapy, and precision medicine, many previously difficult-to-treat autoimmune and rheumatoid immune diseases have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored throughout the treatment process, adjusting the regimen in a timely manner according to changing conditions.
The platform serves the China International Medical Service System, which combines a team of authoritative experts at home and abroad in the field of autoimmunity and rheumatic immunity, to provide the following services to patients: 1. Remote pre-diagnosis: Pre-examination of medical records, clear diagnostic directions and medical advice by the team of experts; 2. Interviews in China: Arrangement with authoritative experts for face-to-face diagnosis, development of personalized treatment plans; 3.
Full-service: One-stop services: medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: Establishment of a chronic disease management file, continuous monitoring of disease changes and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.